Differentiating between diabetic nephropathy (DN) and non-diabetic renal disease (NDRD) without a kidney biopsy remains a major challenge, often leading to missed opportunities for targeted treatments that could greatly improve NDRD outcomes. To reform…
Continue Reading
While circadian disruption is recognized as a potential driver of depression, its real-world impact is poorly understood. A critical step to addressing this is the noninvasive collection of physiological time-series data outside laboratory settings…
Continue Reading
What You Should Know:
– Nonin Medical, a global leader in noninvasive medical monitoring lauches TruO2 OTC, the first over-the-counter (OTC) fingertip pulse oximeter to receive FDA clearance. This innovative device is designed to provide…
Continue Reading
Wearables offer a promising solution for enhancing remote monitoring (RM) of heart failure (HF) patients by tracking key physiological parameters. Despite their potential, their clinical integration faces challenges due to the lack of rigorous…
Continue Reading
Diagnostics startup Geneoscopy earned its first-ever FDA approval this week.
The St. Louis-based company received approval for ColoSense, its noninvasive colorectal cancer screening test. The test — which the FDA designated as a breakthrough device…
Continue Reading
